Avivagen Inc. (OTCMKTS:VIVXF – Get Rating) was the recipient of a significant drop in short interest in October. As of October 15th, there was short interest totalling 2,800 shares, a drop of 64.6% from the September 30th total of 7,900 shares. Based on an average daily volume of 15,900 shares, the days-to-cover ratio is presently 0.2 days.

Avivagen Price Performance

OTCMKTS:VIVXF opened at $0.10 on Thursday. Avivagen has a twelve month low of $0.10 and a twelve month high of $0.38. The stock's 50 day moving average price is $0.12 and its two-hundred day moving average price is $0.14.

Avivagen (OTCMKTS:VIVXF – Get Rating) last posted its quarterly earnings results on Friday, September 16th. The company reported ($0.02) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.02). The firm had revenue of $0.04 million for the quarter, compared to the consensus estimate of $0.23 million. Sell-side analysts anticipate that Avivagen will post -0.08 EPS for the current fiscal year.

Avivagen Company Profile

Avivagen Inc, a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr.

See Also

• Get a free copy of the StockNews.com research report on Avivagen (VIVXF)
• Be Sure You Own United Parcel Service for the Right Reasons
• 3 Roughed-Up Dividend Aristocrats with Good Long-Term Prospects
• Sell-Siders See Value in Highly Valued Chipotle Stock
• Strong Fundamentals Make Bristol Myers Squibb Stock a Real Value
• General Electric May be a Buy in the Right Portfolio

Receive News & Ratings for Avivagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avivagen and related companies with MarketBeat.com's FREE daily email newsletter.